Merion

Merion EBIT CAGR 5Y

The EBIT CAGR (5 Year) of Merion (EWLU) as of Nov 4, 2026 is 9.97 %. In the previous year, EBIT CAGR (5 Year) was 9.97 % — a change of 0.00% (lower).

EBIT CAGR 5Y

9.97 %

YoY

0.00%

Last updated:

EBIT CAGR (5 Year) of Merion is 2021 9.97 % . EBIT CAGR (5 Year) of Merion was 2020 9.97 % . It decreases by 0.00% lower compared to the previous year.

The Merion EBIT CAGR 5Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 5Y
Date
EBIT CAGR 5Y
Jan 1, 2014
9.97 USD
Jan 1, 2015
9.97 USD
Jan 1, 2016
9.97 USD
Jan 1, 2017
9.97 USD
Jan 1, 2018
9.97 USD
Jan 1, 2019
9.97 USD
Jan 1, 2020
9.97 USD
Jan 1, 2021
9.97 USD
The Merion EBIT CAGR 5Y history
YEAREBIT CAGR 5YYoY
9.97 %0.00%
9.97 %0.00%
9.97 %0.00%
9.97 %0.00%
9.97 %0.00%
9.97 %0.00%
9.97 %0.00%
9.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merion Stock analysis

What does Merion do? Merion, Inc. generates revenue by selling its own line of seven nutritional supplements and seven skin-care products through its website dailynu.com. The company's nutritional supplements, including Dibeier Granules & Oral, Longevity, US-Liver Gold, Cell Power, OPC Spa, Heart Power, and O2 Cell Power, are formulated using a micro molecular nutrition process. Its skin-care products, such as anti-aging cream, facial cream, facial serum, body lotion, sun protection, facial toner, and facial cleanser, focus on restoring epidermal calcium. The firm also sells third-party health and nutrition products that are already available through other vendors. The company's primary customers are individuals seeking health and nutritional supplements and personal care products, purchasing directly through dailynu.com. Merion does not manufacture its own skin-care products but distributes third-party brands that are already sold by other vendors. The firm's revenue streams include direct sales of its proprietary supplement line and the third-party products it resells. Merion's business model relies on e-commerce sales via its website, with no physical retail presence. The company's product portfolio is divided into two main segments: its own micro molecular nutrition supplements and third-party health and nutrition products. The skin-care segment focuses on products that restore epidermal calcium, while the nutritional segment features seven proprietary supplements made using its unique formula. Merion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merion stock

EBIT CAGR (5 Year) of Merion is 9.97 % in 2021.

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Merion since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Merion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Merion

All Key Metrics — Merion